The expression of TNF, IL-1β, and TGF-β1 in MM was moderately to strongly correlated with the clinical outcomes (TNF with clinical outcome: VAS LBP (r = 0.410, P = 0.004), VAS leg pain (r = 0.286, P = 0.049), and ODI (r = 0.502, P = 0.000); IL-1β with clinical outcomes: VAS LBP (r = 0.522, P = 0.000), VAS leg pain (r = 0.462, P = 0.001), and ODI (r = 0.449, P = 0.001); TGF-β1 with clinical outcomes: VAS LBP (r = 0.682, P = 0.000), VAS leg pain (r = 0.387, P = 0.012), and ODI (r = 0.354, P = 0.023)). This evidence concerns the gene TNF and Miyoshi myopathy.